This week’s newsletter covers Trump’s executive order directing cannabis rescheduling to Schedule III, federal enforcement challenges around intoxicating hemp products, new research on cannabinoids and ovarian cancer, sleep quality, obesity, cardiovascular health, and a rare […]
This week’s newsletter covers cannabis rescheduling, hemp regulation enforcement hurdles, promising cannabinoid research for Alzheimer’s disease and hypertension, CBD use trends on college campuses, the environmental toll of drug prohibition, and the WHO’s new push […]
This week’s newsletter covers the uncertain fate of cannabis rescheduling under the Trump administration, along with new research on psychedelic polypharmacy, psilocybin’s role in fear extinction and cancer-related depression, and the psychological aftermath of intense […]
This week’s newsletter explores how psychedelic experiences can fuel scientific breakthroughs, alongside a roundup of recent research on CBD’s therapeutic potential across chronic pain, inflammatory bowel disease, Alzheimer’s, cancer, and heart health. Noteworthy Read The […]
This week’s newsletter covers new research on cannabis for treatment-resistant depression, CBD’s potential in cardiovascular health and traumatic brain injury recovery, the therapeutic promise of acidic cannabinoids like THCA and CBDA, and an unexpected interaction […]
This week’s newsletter covers the latest research and journalism on plant medicine, including a landmark study on psilocybin microdosing and creativity, debates over non-hallucinogenic psychedelics, neuroplasticity and addiction treatment, quality control in the psychedelic products […]
This week’s newsletter covers new findings on cannabis and cognitive performance in older adults, the challenges posed by semi-synthetic cannabinoids, CBD’s potential effects on bone health and fetal alcohol spectrum disorder, hemp extract’s role in […]
This week’s newsletter covers promising findings on THC/CBD for dementia care, questions about CBD product labeling accuracy, drug interactions to be aware of during chemotherapy, and a wide-ranging psychedelics research round-up touching on personality change, […]
This week’s newsletter covers MDMA’s potential effects on memory, safety concerns around ibogaine, ethical questions in the psychedelic investment space, new research on CBD and liver health, prenatal cannabis exposure findings, cannabis for migraine relief, […]
This week’s newsletter covers a major analysis exposing synthetic cannabinoids in online hemp products, plus a research round-up on CBD’s potential against melanoma, cannabis roots’ cancer-fighting properties, CBD’s role in neuronal repair, and cannabinoids as […]
© Copyright 2018-2026 HempEtCetera.com, Hemp Et Cetera™ is a unit of SoCal Broadband Inc. All rights reserved.